- iRhythm and Verily collaborate to develop health management solutions for atrial fibrillation patients.- The iRhythm and Verily collaboration aims to address this underserved population at risk for asymptomatic or silent AFib.- iRhythm will make an upfront payment to Verily of $5 million and potential milestone payments of up to $12.75 million.iRhythm Technologies, Inc. is teaming up with Verily, an Alphabet company focused on the development of digital health solutions aimed at improving the
Read More
Verily
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Verily Launches Baseline Health System Consortium with Duke, Mayo, Vanderbilt
Verily, an Alphabet company, today announced a new Project Baseline initiative, the Baseline Health System Consortium, comprised of Verily, Duke University Health System, Vanderbilt University Medical Center, University of Mississippi Medical Center, Mayo Clinic, Regional Health in South Dakota and the University of Pittsburgh. Verily launched Project Baseline in 2017 with the Project Baseline Health Study to develop the technology and tools to help researchers create a more comprehensive map of
Read More
Analysis: How Digital Health Solutions Are Disrupting Care Delivery in Hospitals
Rainer Herzog, Vice President at Research2GuidanceNew stakeholders are entering the hospital arena, contesting the hospitals’ traditional role and freedom to provide care to the community. The newcomers’ focus is on digital care delivery processes and on a digitally enabled patient experience. Hospitals will have to start now to prepare their organizations for the coming change. Creating digital partner ecosystems is one prominent way to approach this task. Hospital stays can be frightening,
Read More
Former ONC Chief Karen DeSalvo Joins LRVHealth as Executive Advisor
Former ONC Chief and Assistant Secretary at HHS joins “Inside Healthcare” investing platform focused on identifying and nurturing digital health innovation. Dr. Karen DeSalvo, who served as National Coordinator for Health Information Technology and Assistant Secretary for Health (Acting) during the Obama administration is joining LRVHealth as an executive advisor. LRVHealth is an early-stage venture platform exclusively focused on finding, investing in and building disruptive new digital health,
Read More
Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson's Progression Markers Initiative will include Verily Study Watch to add new dimension of health data. More than 800 participants will be equipped with Verily's multi-sensor investigational wearable device, to passively collect data on movement and physiologic and environmental measures continuously. The goal is to
Read More
3M, Google’s Verily Life Collaborate to Develop Population Health Tools
3M Health Information Systems and Verily Life Sciences (formerly Google Life Sciences), an Alphabet company has signed a strategic partnership to develop new population health measurement technology for managing clinical and financial performance.The joint technology platform will be designed to analyze quality performance data across healthcare delivery systems and patient populations, and deliver meaningful information that can be used to promote real and sustainable improvements in healthcare
Read More
Google’s Verily, Sanofi Launch $500M Diabetes Joint Venture Onduo
French pharma company Sanofi and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company are teaming up on a $500M joint venture named Onduo to develop a comprehensive diabetes platform. Based in Kendall Square in Cambridge, the Onduo joint venture will combine devices, software, medicine and professional care to enable simple and intelligence disease management for patients. Joshua Riff, M.D., M.B.A will serve as Onduo’s newly appointed Chief Executive Officer. As part
Read More
Verily, GlaxoSmithKline Partner to Develop Bioelectronic Medicines
Alphabet company Verily (formerly Google Life Sciences) is teaming up with pharmaceutical firm GlaxoSmithKline to develop bioelectronic medicines. The new company, Galvani Bioelectronics headquartered in the UK aims to research, develop and commercialize implantable, miniature devices which could potentially treat illnesses such as arthritis, diabetes and asthma. As part of the agreement, GSK will hold 55% equity interest and Verily will hold 45% owned by Verily, and receive up to $712M funding
Read More
